Authors:
HASSAN PC
SPROULE BA
HERRMANN N
REED K
NARANJO CA
Citation: Pc. Hassan et al., DOSE-RESPONSE EVALUATION OF SERTRALINE-ALPRAZOLAM INTERACTION IN HUMANS, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 49-49
Citation: Ba. Sproule et Ca. Naranjo, CLINICAL PSYCHOPHARMACOLOGY FOR MEDICAL-STUDENTS - DEVELOPMENT AND TESTING OF AN EDUCATIONAL PACKAGE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 131-131
Authors:
SPROULE BA
NARANJO CA
BREMNER KE
HASSAN PC
Citation: Ba. Sproule et al., SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND CNS DRUG-INTERACTIONS - ACRITICAL-REVIEW OF THE EVIDENCE, Clinical pharmacokinetics, 33(6), 1997, pp. 454-471
Authors:
BAZOON M
SPROULE BA
TURKSEN IB
NARANJO CA
Citation: M. Bazoon et al., A COMBINED FUZZY-LOGIC NEURAL-NETWORK APPROACH FOR ANALYZING PHARMACOLOGICAL DATA, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 52-52
Authors:
NARANJO CA
SPROULE BA
KERR M
ORTIGOSA A
BREMNER K
Citation: Ca. Naranjo et al., DOES ENHANCING COMPLIANCE WITH PSYCHOPHARMACOTHERAPY IMPROVE OUTCOME, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 74-74
Authors:
SPROULE BA
BUSTO U
GRACIAS D
ROMACH MK
SELLERS EM
Citation: Ba. Sproule et al., PSYCHIATRIC COMORBIDITY AND DEPENDENCE IN REGULAR USERS OF CODEINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 92-92